Regeneron Pharmaceuticals
REGN
#375
Rank
A$91.94 B
Marketcap
A$877.00
Share price
-2.55%
Change (1 day)
10.30%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): A$7.73 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$14.91 Billion. In 2025 the company made an earning of A$7.40 Billion, an increase over its 2024 earnings that were of A$6.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$7.73 B4.42%
2025 A$7.40 B9.43%
2024 A$6.76 B13.83%
2023 A$5.94 B-13.57%
2022 A$6.88 B-47.9%
2021 A$13.20 B144.75%
2020 A$5.39 B56.86%
2019 A$3.44 B-4.87%
2018 A$3.61 B22.86%
2017 A$2.94 B56.3%
2016 A$1.88 B8.55%
2015 A$1.73 B54.53%
2014 A$1.12 B11.14%
2013 A$1.01 B72.13%
2012 A$0.58 B-285.93%
2011 -A$0.32 Billion121.73%
2010 -A$0.15 Billion37.18%
2009 -A$0.11 Billion-14.6%
2008 -A$0.13 Billion-25.02%
2007 -A$0.17 Billion6.32%
2006 -A$0.16 Billion-186.52%
2005 A$0.17 B2103.7%
2004 A$7.99 M-105.66%
2003 -A$0.15 Billion-18.18%
2002 -A$0.18 Billion42.33%
2001 -A$0.13 Billion129.35%
2000 -A$52.91 Million51.87%
1999 -A$34.84 Million92.19%
1998 -A$18.13 Million66.23%
1997 -A$10.91 Million-55.49%
1996 -A$24.51 Million103.53%
1995 -A$12.04 Million-70.89%
1994 -A$41.36 Million-26.08%
1993 -A$55.94 Million114.67%
1992 -A$26.06 Million196.77%
1991 -A$8.79 Million87.88%
1990 -A$4.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.79 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.35 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$12.86 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.84 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$2.29 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.23 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA